DK1718328T3 - Anvendelse af factor XIII til stimulering af gennemblödning i iskæmisk væv - Google Patents

Anvendelse af factor XIII til stimulering af gennemblödning i iskæmisk væv

Info

Publication number
DK1718328T3
DK1718328T3 DK05715335T DK05715335T DK1718328T3 DK 1718328 T3 DK1718328 T3 DK 1718328T3 DK 05715335 T DK05715335 T DK 05715335T DK 05715335 T DK05715335 T DK 05715335T DK 1718328 T3 DK1718328 T3 DK 1718328T3
Authority
DK
Denmark
Prior art keywords
factor xiii
ischemic tissue
bleeding
stimulate
stimulate bleeding
Prior art date
Application number
DK05715335T
Other languages
Danish (da)
English (en)
Inventor
Aida Inbal
Rima Dardik
Jonathan Leor
Gerhard Dickneite
Original Assignee
Csl Behring Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Behring Gmbh filed Critical Csl Behring Gmbh
Application granted granted Critical
Publication of DK1718328T3 publication Critical patent/DK1718328T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45Transferases (2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DK05715335T 2004-02-20 2005-02-15 Anvendelse af factor XIII til stimulering af gennemblödning i iskæmisk væv DK1718328T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04003950A EP1566183A1 (en) 2004-02-20 2004-02-20 Use of factor XIII for stimulating the perfusion of ischemic tissue
PCT/EP2005/001495 WO2005079839A1 (en) 2004-02-20 2005-02-15 Use of factor xiii for stimulating the perfusion of ischemic tissue

Publications (1)

Publication Number Publication Date
DK1718328T3 true DK1718328T3 (da) 2009-07-27

Family

ID=34707356

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05715335T DK1718328T3 (da) 2004-02-20 2005-02-15 Anvendelse af factor XIII til stimulering af gennemblödning i iskæmisk væv

Country Status (11)

Country Link
US (1) US20070167361A1 (https=)
EP (2) EP1566183A1 (https=)
JP (1) JP2007523111A (https=)
KR (1) KR20060123567A (https=)
AT (1) ATE429244T1 (https=)
AU (1) AU2005215114B2 (https=)
CA (1) CA2556805C (https=)
DE (1) DE602005014085D1 (https=)
DK (1) DK1718328T3 (https=)
ES (1) ES2325996T3 (https=)
WO (1) WO2005079839A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20130532A1 (it) * 2013-06-27 2014-12-28 Donato Gemmati Nuovo biomarcatore prognostico nell'infarto acuto del miocardio

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69431430T2 (de) * 1993-03-30 2003-05-22 Hoechst Japan Ltd., Tokio/Tokyo Faktor XIII zur Behandlung von Hautwunden
AU7483798A (en) * 1997-05-14 1998-12-08 Zymogenetics Inc. Use of factor xiii for the manufacture of a medicament for the treatment of reperfusion injury and mucosal damage
EP1572168B1 (en) * 2002-02-06 2010-05-26 Vicor Technologies, Inc. Anti-infarction molecules

Also Published As

Publication number Publication date
ATE429244T1 (de) 2009-05-15
CA2556805C (en) 2013-04-02
KR20060123567A (ko) 2006-12-01
EP1718328A1 (en) 2006-11-08
AU2005215114B2 (en) 2010-05-20
EP1566183A1 (en) 2005-08-24
WO2005079839A1 (en) 2005-09-01
DE602005014085D1 (de) 2009-06-04
US20070167361A1 (en) 2007-07-19
EP1718328B1 (en) 2009-04-22
ES2325996T3 (es) 2009-09-28
JP2007523111A (ja) 2007-08-16
AU2005215114A1 (en) 2005-09-01
CA2556805A1 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
NI200800169A (es) Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento del dolor
EA200970446A1 (ru) Связывающиеся с альбумином молекулы и их применение
LTC2292737I2 (lt) Panaudojimas iš adipozinio audinio kilusių stromos kamieninių ląstelių fistulų gydyme
ATE528007T1 (de) Lagerstabile infusionslösung von dihydropteridinonen
CY1119988T1 (el) Αναστολεις του ιου της ηπατιτιδας c
DK1639953T3 (da) Endomedullært söm til behandling af proximale femurfrakturer
EA200802213A1 (ru) Способы лечения заболеваний крови
BRPI0814737A2 (pt) Composição, métodos para reduzir, retardar ou de um outro modo inibir o crescimento e/ou replicação de hcv, para prevenir a infecção de uma célula exposta a hcv, para tratar terapeuticamente ou profilaticamente um paciente exposto ou infectado com hcv, e para tratar hepatite c, e, uso de uma composição.
CY1113736T1 (el) Ετεροαρυλ-ουριες και η χρηση τους ως ενεργοποιητες γλυκοκινασης
NO20065227L (no) Menoklonale antistoff mot hepatocytt vekstfaktor
NI200800176A (es) Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento de la depresión
ATE525070T1 (de) Silbininkomponente zur behandlung von hepatitis
UY28734A1 (es) Compuestos de quinolina sustituidos
NO20083032L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av mani og bipolar forstyrrelse
CU20100032A7 (es) Depsipéptidos cíclicos
ATE542521T1 (de) Verfahren und zusammensetzungen zur verstärkung der lebensfähigkeit von mikronadelporen
ATE438623T1 (de) Aroyl-o-piperidinderivate zur behandlung von problemen im zusammenhang mit diabetes
ATE472324T1 (de) Isosorbid-mononitrat-derivate zur behandlung von okularer hypertonie
ATE460923T1 (de) Lyophilisierung von virosomen
EP1888102A4 (en) MODULATION OF PERIPHERAL TAKES ON ADIPOSITAS TISSUE
UY29036A1 (es) Derivados de oxopiperidina, su preparacion y su aplicacion en terapeutica
DK2121142T3 (da) Anvendelse af GDF-5 til forbedring eller vedligeholdelse af hudens udseende
EA200970506A1 (ru) Применение индазолметоксиалкановой кислоты для снижения уровней триглицеридов, холестерина и глюкозы
DK1718328T3 (da) Anvendelse af factor XIII til stimulering af gennemblödning i iskæmisk væv
EP1872815A4 (en) CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY